InMode (INMD) Set to Announce Quarterly Earnings on Tuesday

InMode (NASDAQ:INMDGet Free Report) is set to release its earnings data before the market opens on Tuesday, February 13th. Analysts expect InMode to post earnings of $0.54 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

InMode Trading Up 2.4 %

Shares of NASDAQ INMD opened at $25.96 on Friday. InMode has a 12-month low of $18.57 and a 12-month high of $48.25. The stock has a market cap of $2.15 billion, a PE ratio of 12.36 and a beta of 2.22. The company has a 50-day moving average of $22.65 and a 200 day moving average of $27.80.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on INMD. UBS Group reaffirmed a “neutral” rating and set a $24.00 price objective (down previously from $52.00) on shares of InMode in a research note on Friday, November 3rd. Barclays dropped their price target on shares of InMode from $33.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, January 18th. Canaccord Genuity Group reissued a “hold” rating and issued a $22.00 price target on shares of InMode in a research note on Thursday, December 7th. Finally, TheStreet cut shares of InMode from a “b-” rating to a “c+” rating in a research note on Thursday, October 19th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, InMode presently has a consensus rating of “Hold” and an average target price of $36.83.

View Our Latest Stock Analysis on InMode

Institutional Investors Weigh In On InMode

A number of hedge funds have recently added to or reduced their stakes in the business. MML Investors Services LLC raised its holdings in shares of InMode by 54.8% in the 1st quarter. MML Investors Services LLC now owns 8,947 shares of the healthcare company’s stock valued at $286,000 after purchasing an additional 3,167 shares in the last quarter. Atria Wealth Solutions Inc. acquired a new stake in shares of InMode in the 1st quarter valued at $276,000. Prudential Financial Inc. raised its holdings in shares of InMode by 31.5% in the 1st quarter. Prudential Financial Inc. now owns 7,562 shares of the healthcare company’s stock valued at $242,000 after purchasing an additional 1,810 shares in the last quarter. Thrivent Financial for Lutherans acquired a new stake in shares of InMode in the 1st quarter valued at $230,000. Finally, Boothbay Fund Management LLC purchased a new position in shares of InMode in the 4th quarter valued at $213,000. 65.49% of the stock is currently owned by institutional investors and hedge funds.

About InMode

(Get Free Report)

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

See Also

Earnings History for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.